Denali Therapeutics Inc (DNLI)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$19.57

Buy

$21.22

arrow-up$0.09 (+0.43%)

Prices updated at 30 May 2026, 00:59 EDT

Prices minimum 15 mins delay

Prices in USD

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

NASDAQ

0.2%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$21.18 - $20.84
	$23.77 - $12.58
	-
	3,339.25m
	-
	-
	1,699,843
	3.61
	1,766,886.79
	1.58
	156.18m
	US24823R1059
	-2.88
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.